⌘K
Loading ticker…
As of 2026-08-24, Dermata Therapeutics, Inc. Common Stock (DRMA) has a 3-month relative strength percentile of 87 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 47. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 11.4%, relative volume 0.10×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DRMA Jan avg: -16.13% median: -14.24% win: 0% σ: 13.19% n: 4 2022-04-12 → 2026-07-31 | DRMA Feb avg: -16.37% median: -6.87% win: 0% σ: 20.22% n: 4 2022-04-12 → 2026-07-31 | DRMA Mar avg: -20.98% median: -7.88% win: 25% σ: 32.34% n: 4 2022-04-12 → 2026-07-31 | DRMA Apr avg: -2.41% median: -9.65% win: 40% σ: 21.75% n: 5 2022-04-12 → 2026-07-31 | DRMA May avg: -13.55% median: -14.09% win: 0% σ: 9.72% n: 5 2022-04-12 → 2026-07-31 | DRMA Jun avg: -14.15% median: -16.68% win: 20% σ: 16.27% n: 5 2022-04-12 → 2026-07-31 | DRMA Jul avg: -12.52% median: -10.60% win: 20% σ: 13.16% n: 5 2022-04-12 → 2026-07-31 | DRMA Aug avg: -3.32% median: -3.27% win: 25% σ: 3.86% n: 4 2022-04-12 → 2026-07-31 (current) | DRMA Sep avg: -10.39% median: -10.65% win: 0% σ: 3.91% n: 4 2022-04-12 → 2026-07-31 | DRMA Oct avg: -18.01% median: -27.22% win: 25% σ: 31.34% n: 4 2022-04-12 → 2026-07-31 | DRMA Nov avg: 1.31% median: -5.27% win: 25% σ: 17.48% n: 4 2022-04-12 → 2026-07-31 | DRMA Dec avg: -15.30% median: -22.14% win: 25% σ: 24.49% n: 4 2022-04-12 → 2026-07-31 |